| 1 |
27165125 | Sex differences in the serum level of endogenous ligands for estrogen receptor β in the elderly population. | 2016 May 11 |
1 |
| 2 |
24077289 | Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer. | 2014 Aug 14 |
1 |
| 3 |
24845419 | Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor. | 2014 Jul 5 |
1 |
| 4 |
23515287 | The androgen metabolite, 5α-androstane-3β,17β-diol (3β-diol), activates the oxytocin promoter through an estrogen receptor-β pathway. | 2013 May |
6 |
| 5 |
22542504 | Estrogen receptor beta dependent attenuation of cytokine-induced cyclooxygenase-2 by androgens in human brain vascular smooth muscle cells and rat mesenteric arteries. | 2012 Jul |
1 |
| 6 |
23117931 | The androgen metabolite, 5α-androstane-3β,17β-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells. | 2012 Dec |
3 |
| 7 |
22114194 | Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer. | 2011 Dec 13 |
4 |
| 8 |
20385358 | ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. | 2010 Apr 13 |
1 |
| 9 |
20562232 | Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol. | 2010 Sep |
4 |
| 10 |
20646931 | ERbeta: recent understanding of estrogen signaling. | 2010 Sep |
1 |
| 11 |
18331353 | CYP7B1-mediated metabolism of dehydroepiandrosterone and 5alpha-androstane-3beta,17beta-diol--potential role(s) for estrogen signaling. | 2008 Apr |
3 |
| 12 |
17639508 | Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma. | 2007 Sep 15 |
2 |
| 13 |
15958594 | The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. | 2005 Jun 15 |
4 |